To the Editor Joseph et al¹ conducted a nationwide analysis of resuscitative endovascular balloon occlusion of the aorta (REBOA) using the 2015 to 2016 American College of Surgeons Trauma Quality Improvement Program data set. The authors reported higher rates of 24-hour mortality and complications, including amputation and acute kidney injury in patients undergoing REBOA than those who were not.¹ These results were consistent with those from the Japan Trauma Data Bank.^2,3 The potential limitations of the article included the unavailability of data on the duration of occlusion, occluded zone of the aorta, and the use of partial REBOA; moreover, the use of a new device compatible with a 7-Fr sheath should have limited the risk of leg ischemia.

要编辑Joseph等¹进行使用二〇一五年至2016年美国外科学院创伤质量改善计划的数据集主动脉（REBOA）的复苏血管内球囊栓塞的全国性分析。作者报告说，接受REBOA治疗的患者的24小时死亡率和并发症（包括截肢和急性肾损伤）的发生率比未接受治疗的患者更高。¹这些结果与日本创伤数据库的结果一致。^{2 ，3-}该文章的潜在局限性包括无法获得有关闭塞持续时间，主动脉闭塞区域以及使用部分REBOA的数据。此外，使用与7-Fr护套兼容的新设备应该可以减少腿部缺血的风险。